FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975829215> ?p ?o ?g. }

• W2975829215 endingPage "e17147" @default.
• W2975829215 startingPage "e17147" @default.
• W2975829215 abstract "Abstract The study aims to examine the treatment effect and adverse reactions of patients with newly diagnosed MM receiving different bortezomib-based regimens. This was a retrospective study of patients with newly diagnosed MM and who were treated with bortezomib-based combined chemotherapy at the Department of Hematology of the 2 affiliated hospitals of Wenzhou Medical University between July 2009 and May 2016. Cox proportion hazard multivariate analyses were carried out to assess the differences in treatment effect and adverse events between standard (1.3 mg/m 2 on days 1, 4, 8, 11) and weekly (1.6 mg/m 2 on days 1, 8, 15) cohorts, as well as the differences between intravenous injection and subcutaneous injection therapy. Progression-free survival (PFS) and overall survival (OS) were assessed using Kaplan–Meier method and the log-rank test. Among the 117 patients, 78 patients were treated with bortezomib standard therapy and 39 patients were treated with bortezomib weekly therapy (all with intravenous injection). In all patients, the treatment strategy was not independently associated with PFS or OS. The patients in the weekly therapy group had less thrombocytopenia events than those in the standard therapy group. The subcutaneous route had similar treatment effect as the intravenous route, but the incidence of peripheral neuropathy was lower. The once-weekly bortezomib regimen was similar in effectiveness to standard therapy in treating patients with newly diagnosed MM, but the incidence of thrombocytopenia was lower with the weekly regimen compared with the standard regimen." @default.
• W2975829215 created "2019-10-03" @default.
• W2975829215 creator A5000196442 @default.
• W2975829215 creator A5006195619 @default.
• W2975829215 creator A5010617525 @default.
• W2975829215 creator A5012541451 @default.
• W2975829215 creator A5012873527 @default.
• W2975829215 creator A5034750589 @default.
• W2975829215 creator A5048383714 @default.
• W2975829215 creator A5055831532 @default.
• W2975829215 creator A5088404530 @default.
• W2975829215 date "2019-09-01" @default.
• W2975829215 modified "2023-09-26" @default.
• W2975829215 title "Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China" @default.
• W2975829215 cites W1504123643 @default.
• W2975829215 cites W1586223754 @default.
• W2975829215 cites W1608379611 @default.
• W2975829215 cites W1631344123 @default.
• W2975829215 cites W1864129297 @default.
• W2975829215 cites W1955748620 @default.
• W2975829215 cites W1972519999 @default.
• W2975829215 cites W1985947990 @default.
• W2975829215 cites W1999549312 @default.
• W2975829215 cites W2015003025 @default.
• W2975829215 cites W2016379765 @default.
• W2975829215 cites W2038378122 @default.
• W2975829215 cites W2049852979 @default.
• W2975829215 cites W2066800926 @default.
• W2975829215 cites W2068889400 @default.
• W2975829215 cites W2070790769 @default.
• W2975829215 cites W2083107653 @default.
• W2975829215 cites W2088374070 @default.
• W2975829215 cites W2111650326 @default.
• W2975829215 cites W2117510998 @default.
• W2975829215 cites W2120431978 @default.
• W2975829215 cites W2136396125 @default.
• W2975829215 cites W2144728882 @default.
• W2975829215 cites W2151583622 @default.
• W2975829215 cites W2160088903 @default.
• W2975829215 cites W2160188479 @default.
• W2975829215 cites W2166059514 @default.
• W2975829215 cites W2169183166 @default.
• W2975829215 cites W2175897615 @default.
• W2975829215 cites W2505186248 @default.
• W2975829215 cites W2522241980 @default.
• W2975829215 cites W2522875414 @default.
• W2975829215 cites W2546436011 @default.
• W2975829215 cites W2552904253 @default.
• W2975829215 cites W2559593973 @default.
• W2975829215 cites W2575800978 @default.
• W2975829215 cites W2593428949 @default.
• W2975829215 cites W2596138695 @default.
• W2975829215 cites W2734904855 @default.
• W2975829215 cites W2790148946 @default.
• W2975829215 cites W4211135634 @default.
• W2975829215 cites W600387072 @default.
• W2975829215 doi "https://doi.org/10.1097/md.0000000000017147" @default.
• W2975829215 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6775427" @default.
• W2975829215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31574817" @default.
• W2975829215 hasPublicationYear "2019" @default.
• W2975829215 type Work @default.
• W2975829215 sameAs 2975829215 @default.
• W2975829215 citedByCount "4" @default.
• W2975829215 countsByYear W29758292152020 @default.
• W2975829215 countsByYear W29758292152021 @default.
• W2975829215 countsByYear W29758292152023 @default.
• W2975829215 crossrefType "journal-article" @default.
• W2975829215 hasAuthorship W2975829215A5000196442 @default.
• W2975829215 hasAuthorship W2975829215A5006195619 @default.
• W2975829215 hasAuthorship W2975829215A5010617525 @default.
• W2975829215 hasAuthorship W2975829215A5012541451 @default.
• W2975829215 hasAuthorship W2975829215A5012873527 @default.
• W2975829215 hasAuthorship W2975829215A5034750589 @default.
• W2975829215 hasAuthorship W2975829215A5048383714 @default.
• W2975829215 hasAuthorship W2975829215A5055831532 @default.
• W2975829215 hasAuthorship W2975829215A5088404530 @default.
• W2975829215 hasBestOaLocation W29758292151 @default.
• W2975829215 hasConcept C120665830 @default.
• W2975829215 hasConcept C121332964 @default.
• W2975829215 hasConcept C126322002 @default.
• W2975829215 hasConcept C141071460 @default.
• W2975829215 hasConcept C167135981 @default.
• W2975829215 hasConcept C194409129 @default.
• W2975829215 hasConcept C197934379 @default.
• W2975829215 hasConcept C207103383 @default.
• W2975829215 hasConcept C2776364478 @default.
• W2975829215 hasConcept C2777478702 @default.
• W2975829215 hasConcept C2781413609 @default.
• W2975829215 hasConcept C44249647 @default.
• W2975829215 hasConcept C61511704 @default.
• W2975829215 hasConcept C71924100 @default.
• W2975829215 hasConceptScore W2975829215C120665830 @default.
• W2975829215 hasConceptScore W2975829215C121332964 @default.
• W2975829215 hasConceptScore W2975829215C126322002 @default.
• W2975829215 hasConceptScore W2975829215C141071460 @default.
• W2975829215 hasConceptScore W2975829215C167135981 @default.
• W2975829215 hasConceptScore W2975829215C194409129 @default.
• W2975829215 hasConceptScore W2975829215C197934379 @default.

• next